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ABSTRACT 
Besides delivering drug to the body, a drug delivery system aims to improve patient compliance, patient acceptance. The dosage forms 
available for the delivery of topical agents include ointment, paste, lotion, moisturizing cream and powder. However, Gel is more preferable 
due to their properties. Present research work is attempted to develop gel by using rice bran wax. Rice bran wax is the vegetable wax 
extracted from rice bran oil. The oil generally contains 2–6% wax. However it is assumed that on an average it contains 3% wax. 
Physicochemical tests such as globule size, evaluation of the intrinsic viscosity and homogeneity of Gel products, have been traditionally 
used to provide reasonable evidence of consistent product performance. However, for the purposes of these studies, the final gel products 
were characterized for their clarity, pH, viscosity, spread ability, skin irritation test and in vitro diffusion studies using standard procedure. 
All the results match with official specifications. 
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INTRODUCTION  
Waxes (animal and plants) are esters of high molecular 
weight monohydroxy alcohols and high molecular weight 
carboxylic acids. They are chemically different from fats 
and oils, from hydrocarbon or paraffin waxes, and from 
synthetic polyether waxes such as carbowax
1
. During the 
past few decades a number of non conventional vegetable 
oils have been accepted as good quality edible oils in India 
and in other countries. Since India is one of the principle 
producers of rice in the world enormous stress is laid upon 
the extraction of oil from rice bran. Rice bran is the brown 
layer between the rice and outer husk of the paddy. The 
bran is obtained as the by-product in rice milling. Rice bran 
contains around 15-20% of oil, which can be economically 
obtained only by solvent extraction process. Rice bran oil is 
now gaining importance as one of the edible oils in India 
because of its nutritional property. Crude rice bran wax is 
dark brown in color and has its own typical physical and 
chemical composition. The literature survey reveals that 
rice bran wax has been used in cosmetics and toiletries. 
Unfortunately the details of this literature are not available. 
Rice bran wax is also utilized as an ingredient for coating 
candy and chewing gums. But the utilization of rice bran 
wax in pharmaceuticals is meager or hardly there is any 
report inspite of large production. Therefore the rice bran 
wax utilization in pharmaceuticals is worth investigating. 
Keeping in view the potential availability of rice, its 
contents such as oils and wax an attempt is made to utilize 
rice bran wax as pharmaceutical aid. 
Recent work indicates that rice bran wax is mainly an ester 
of lignoceric acid and myricyl alcohol. The hard nontacky 
wax separately recovered is reported to be chiefly melissyl 
cerotate and melts at about 80-85°. Research had showed 
that the properties of the refined and bleached wax are 
similar to those of presently imported carnauba wax 
2
. 
Present study attempts to find if rice bran wax is useful as 
gel base. The gel base is prepared by using rice bran wax 
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and evaluated for their clarity, pH, viscosity, spreadability, 
skin irritation test and in vitro diffusion studies using 
standard procedure. 
MATERIALS AND METHODS 
Econazole and 5 FU of pharmaceutical grade were obtained 
as gift sample from Euphoria ealthcare Pvt. Ltd. Mumbai. 
Rice bran wax obtained from Triveni Interchem Pvt Ltd., 
Vapi, Gujarat, India. All other reagents and chemicals used 
were of analytical reagent grade. 
Formulation development Gel  
Appropriate quantity of carbopol 934 and rice bran wax 
were soaked in water for a period of 2 hours. Carbopol and 
rice bran wax was then neutralized by adding 
triethanolamine (TEA) with stirring. Then required amount 
of drug was dissolved in appropriate and pre weighted 
amounts of propylene glycol and ethanol. Then solvent 
blend was transferred to carbopol and rice bran wax 
container and agitated for 20 min. The dispersion was then 
allowed to hydrate and swell for 60 min, finally pH was 
adjusted to 6.8-7.0 by adding 98% TEA until the desired 
pH value was reached. During pH adjustment, the mixture 
was stirred gently with a spatula until homogeneous gel 
was formed. All the samples were allowed to equilibrate for 
24 hours at room temperature prior to performing 
rheological measurements 
3, 4 , 5 
 
Formulation development of gel of econazole 
Table 1: Formulation GE1to GE9 
Ingredient 
(% w/w) 
Formulation Code 
GE1 GE2 GE3 GE4 GE5 GE6 GE7 GE8 GE9 
Econazole 1 1 1 1 1 1 1 1 1 
Carbopol 0.1 0.15 0.2 0.25 0.30 0.35 0.40 0.5 0.55 
Rice bran wax 0.55 0.50 0.45 0.40 0.35 0.30 0.25 0.20 0.15 
Propylene Glycol 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 
Triethanolamine 2 2 2 2 2 2 2 2 2 
Methyl Paraben 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 
Propyl paraben 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 
Distill. water q.s q.s q.s q.s q.s q.s q.s q.s q.s 
 
Formulation development of gel of 5- fluorouracil 
Table 2: Formulation GF1 to GF9 
Ingredient (% w/w) Formulation Code 
GF1 GF2 GF3 GF4 GF5 GF6 GF7 GF8 GF9 
Econazole 1 1 1 1 1 1 1 1 1 
Carbopol 0.1 0.15 0.2 0.25 0.30 0.35 0.40 0.5 0.55 
Rice bran wax 0.55 0.50 0.45 0.40 0.35 0.30 0.25 0.20 0.15 
Propylene Glycol 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 
Triethanolamine 2 2 2 2 2 2 2 2 2 
Methyl Paraben 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 
Propyl paraben 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 
Distill. water q.s q.s q.s q.s q.s q.s q.s q.s q.s 
 
Evaluation of gel 
Characterization of developed formulation
4, 6, 7, 8
 
Gel was evaluated for their clarity, pH, viscosity, 
spreadability, skin irritation test, in vitro diffusion studies 
using standard procedure.  
Psychorheological Characteristic 
The Psychorheological Characteristic was checked for gel 
formulations (colour, clogging, homogeneity and texture) 
and observations. 
Consistency or hardness of gel 
It was measured by Penetrometer. Three samples were 
stored at 25+ 0.50C and with shear for 5 min. Three 
samples were melted and carefully and completely filled 
three containers, without forming air bubbles stored at 25+ 
0.50C for 24 hrs. Test samples were placed on 
Penetrometer. Penetrating object was released for 5 sec. 
Depth of penetration was measured. 
Washability 
Gel Formulations were applied on the skin and then ease 
and extent of washing with water were checked manually 
and observations. 
Extrudability study 
The gel formulations were filled into collapsible metal 
tubes or aluminium collapsible tubes.  The tubes were 
pressed to extrude the material and the extrudability of the 
formulation was checked.       
Spreadability 
Two glass slides of standard dimensions (6×2) were 
selected. The gel formulation whose spreadability had to be 
determined was placed over one of the slides. The second 
slide was placed over the slide in such a way that the 
formulation was sandwiched between them across a length 
of 6 cms along the slide. 100 grams of weight was placed 
up on the upper slide so that the topical gel formulation 
between the two slides was traced uniformly to form a thin 
layer.  
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The weight was removed and the excess of the gel 
formulation adhering to the slides was scrapped off. The 
lower slide was fixed on the board of the apparatus and one 
end of the upper slide was tied to a string to which 20 gram 
load could be applied   50with the help of a simple pulley. 
The time taken for the upper slide to travel the distance of 6 
cms and separate away from lower slide under the direction 
of the weight was noted. The experiment was repeated and 
the average of 6 such determinations was calculated for 
each topical gel formulation. 
 
  Where, S = Spreadability (gcm/sec) 
  m = weight tied to the upper slide (20 grams)   
  l = length of glass slide (6cms).   t = time taken is seconds. 
Determination of pH 
The pH of the gel was determined by digital pH meter. 
Viscosity 
The measurement of viscosity of the prepared gel was done 
using Brookfield digital Viscometer.  
 In-vitro drug release studies using the prehydrated 
cellophane membrane 
 Preparation of cellophane membrane for the 
diffusion studies:  
The cellophane membrane approximately 25 cm x 2cm was 
taken and washed in the running water. It was then soaked 
in distilled water for 24 hours, before used for diffusion 
studies to remove glycerin present on it and was mounted 
on the diffusion cell for further studies. 
 Diffusion Studies:  
The in-vitro diffusion of drug from the different gel 
preparations were studied using the classical standard 
cylindrical tube fabricated in the laboratory; a simple 
modification of the cell is a glass tube of 15mm internal 
diameter and 100mm height. The diffusion cell membrane 
was applied with one gram of the formulation and was tied 
securely to one end of the tube, the other end kept open to 
ambient conditions which acted as donor compartment. The 
cell was inverted and immersed slightly in 250 ml of 
beaker containing phosphate buffer, freshly prepared (pH 
7.4) as a receptor base and the system was maintained for 2 
hrs at 37± 0.5
o
 C. Aliquots, each of 5 ml volume were 
withdrawn periodically at predetermined time interval of 
15, 30, 45, 60, 90, 120 min and replaced by an equal 
volume of the receptor medium. The aliquots were suitably 
diluted with the receptor medium and analyzed by UV-Vis 
spectrophotometer at 233.0nm for econazole and 264nm 
for 5-FU using phosphate buffer as blank. 
Data Analysis via drug release kinetics study
8-10
 
The results of in-vitro release profile obtained for all the 
formulations were plotted in kinetic models as follows,  
1.  Cumulative of drug released versus time (zero order 
kinetic model).  
2.  Log cumulative percent drug remaining to be absorbed 
versus time (First order model)  
3. Cumulative amount of drug release versus square root of 
time (Higuchi model)  
4.  Log cumulative drug released versus log time 
(Korsmeyer-Peppas model) 
Zero order release kinetics:  
Zero order release would be predicted by the following 
equation, 
Qt = QO+ Kt 
Where, Qt is the amount of drug dissolved in time t,  
Q0 is the initial amount of drug in the solution (most times, 
Q0=0) and K is the zero order release constant. 
First order release kinetics:  
First order release would be predicted by the following 
equation,  
 
Where, Qt is the amount of drug released in time t, 
Q0 is the initial amount of drug in the solution and 
K is the first order release constant.  
Higuchi kinetics:  
This equation describes drug release as a diffusion process 
based on the Flick's Law, Square root time dependent. 
Q=Kt
1/2 
Q=Amount of drug release per unit area in time t, 
K=release rate constant 
Peppas & korsemeyer equation 
The amount of drug released at time t (Mt) with respect to 
the total amount of drug released (M∞), can be expressed in 
terms of an exponential expression as follows: 
 
Where, Mt / M∞ = The fraction of drug released at time t, 
K = Constant incorporating the structural and geometrical 
characteristic of the drug /polymer system.  
n = diffusion exponent related to the release    
Skin irritation studies of developed formulations
8,10
 
Animals:- 
Wistar rats (150–200 g) were group housed (n= 6) under a 
standard 12 h light/dark cycle and controlled conditions of 
temperature and humidity (25±2 °C). Rats received 
standard rodent chow and water ad libitum. Separate group 
(n=6) of rats was used for each set of experiments. The 
animal studies were approved by the Institutional Animal 
Ethics Committee (IAEC), constituted for the purpose of 
control and supervision of experimental animals by 
Ministry of Environment and Forests, Government of India, 
New Delhi, India. 
Skin irritation study  
The rats were divided into three groups (n = 4) and 
formulations were topically applied, i.e. The formulations 
were uniformly applied over the shaven skin of rats. The 
skin was observed for any visible changes such as erythema 
(redness) or edema at 24, 48, and 72 h after the application 
of various formulations, and the primary irritation index 
was calculated. For each animal, the primary irritation 
scores were added together for the test formulation for both 
erythema and edema at each time specified and divided by 
the total number of observations. The scores for each 
animal was added and divided by the total no of animals to 
give the primary irritation index. The primary irritation 
index was characterized by number (score) and description 
(response category). 
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Group V- Formulation II (Gel) 
Statistical analysis 
The values were expressed as mean ± SEM. The statistical 
significance was assessed using one-way analysis of 
variance (ANOVA) followed by Tukey’s test and P<0.05, 
P<0.01, and P<0.001 were considered to be statistically 
significant. 
In-vitro antifungal activity 
Media preparation (broth and agar media) 
Composition of Potato Dextrose agar media; 
Agar                              -    20 gms. 
Potato infusion            -    200 gms. 
Dextrose infusion        -    20 gms. 
Distilled water              -    to make 1000 ml. 
pH                                 -    7 
Method of preparation  
This agar medium was dissolved in distilled water and 
boiled in conical flask of sufficient capacity. Dry 
ingredients are transferred to flask containing required 
quantity of distilled water and heat to dissolve the medium 
completely. 
Sterilization culture media 
The flask containing medium was cotton plugged and was 
placed in autoclave for sterilization at 15 lbs /inch
2
 (121
o
C) 
for 15 minutes.  
Preparation of plates  
After sterilization, the potato dextrose agar in flask was 
immediately poured (20 ml/ plate) into sterile Petri dishes 
on plane surface. The poured plates were left at room 
temperature to solidify and incubate at 37
o
C overnight to 
check the sterility of plates. The plates were dried at 50
o
C 
for 30 minutes before use. 
Revival of the fungal cultures 
The fungal cultures used in the study were obtained in 
lyophilized form. With the help aseptic techniques the 
lyophilized cultures are inoculated in sterile potato dextrose 
broth than incubated for 24 hours at 37
o
C. After incubation 
the growth is observed in the form of turbidity. These broth 
cultures were further inoculated on to the potato dextrose 
agar plates with loop full of fungus and further incubated 
for next 24 hours at 37
o
C to obtain the pure culture and 
stored as stocks that are to be used in further research work. 
Anti fungal sensitivity  
The anti fungal sensitivity test is employed on to the 
microbes against Candida Albicans. For this experiment 6 
mm diameter wells, stock of 30µg/ml of given sample 
separately applied on it. A potato dextrose plate is seeded 
with particular fungus with the help of spread plate 
technique prior and left for 5 minutes then incubated for 24 
hours at 37
o
C. After incubation, plates were observed to see 
the sensitivity of formulation towards test bacteriums at 
particular concentration in the form zone of inhibition. 
Antibiogram Studies 
Broth cultures of the pure culture isolates of those test 
microorganisms which are sensitive towards the 
formulations used in present study were prepared by 
transferring a loop of culture into sterile potato dextrose 
broth and incubated at 37
o
C for 24-48hours. A loop full 
was taken from these broths and seeded onto sterile potato 
dextrose agar plates through sterile cotton swab to develop 
diffused heavy lawn culture. The well diffusion method 
was used to determine the antifungal activity of 
formulation of rice bran wax using standard procedure 
(Bauer, 1966). There were 3 concentration used which are 
30, 20 and 10 µg/ml for each formulations in antibiogram 
studies. It’s essential feature is the placing of wells with the 
antibiotics on the surfaces of agar immediately after 
inoculation with the organism tested. Undiluted over night 
broth cultures should never be used as an inoculums. The 
plates were incubated at 37
o
C for 24 hr. and then examined 
for clear zones of inhibition around the wells impregnated 
with particular concentration of drug. 
Stability studies  
Stability studies of optimize formulation of cream, 
ointment and gel 
The prepared gels were packed in aluminium collapsible 
tubes and subjected to stability studies at 40±2°C/75±5% 
RH and 30±2°C/60±5% RH as per ICH guidelines for a 
period of 3 months. Samples were withdrawn at 1 month 
time intervals and evaluated for physical appearance, pH, 
rheological properties, drug content and in vitro drug 
release. 
RESULTS AND DISCUSSION  
Topical gel formulation was developed using rice bran 
wax. Polymer and active drug concentration were chosen as 
independent variables while spreadability, extrudability and 
viscosity as dependent factors. In order to carry out an 
overview and a critical analysis of skin decontamination, 
topical lotion formulation was developed successfully and 
analyzed for decontamination efficacy and dermal toxicity 
applying the different formulas and statistical approaches.  
Characterization of gel formulation 
 
Table 3: Characterization of formulations GE1 to GE4 
Parameters 
Formulation 
GE1 GE2 GE3 GE4 
Physical Appearance 
Translucent, white, 
smooth on application 
Translucent, white, 
smooth on application 
Translucent, white, 
smooth on application 
Translucent, white, 
smooth on application 
pH 7.01±0.3 6.82±0.1 6.95±0.6 6.90±0.8 
Viscosity (CP) 30514±7.3 31412±16.4 32878±22.8  31454 ±4.6 
Spreadability (gm.cm/sec)          16.46±4.6 16.31±0.58 15.54±1.39 16.35± 1.11 
% Drug content 99.10±0.4 98.20±0.3 97.70±0.9 97.78±0.4 
Extrudability +++ +++ +++ +++ 
+++ Excellent, ++ Good, + Satisfactory 
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Table 4: Characterization of formulations GE5 to G E9 
Parameters 
Formulation  
GE5 GE6 GE7 GE8 GE9 
Physical 
Appearance 
Translucent, white, 
smooth on 
application 
Translucent, 
white, smooth on 
application 
Translucent, 
white, smooth on 
application 
Translucent, 
white, smooth on 
application 
Translucent, white, 
smooth on application 
Ph 6.95±0.3 6.85±0.1 7±0.3 7.03±0.2 7.03±0.2 
Viscosity (CP) 32250±7.3 32554±16.4 33510±22.8          34454±3.6          34815±3.6 
Spreadability 
(gm.cm/sec) 
        15.59±4.5 14.31±0.58 13.45±1.39 13.15± 3.10 12.15± 3.10 
% Drug content 99.10±0.4 96.20±0.3 97.70±0.9 98.95±0.4 98.95±0.4 
Extrudability +++ +++ +++ +++ +++ 
 
Table 5: Characterization of formulations GF1 to GF4 
Parameters 
Formulation 
GF1 GF2 GF3 GF4 
Physical Appearance 
Translucent, white, 
smooth on application 
Translucent, white, 
smooth on application 
Translucent, white, 
smooth on application 
Translucent, white, 
smooth on application 
pH 6.98±0.2 6.82±0.2 6.98±0.3 6.85±0.4 
Viscosity (CP) 30145±8.9 30989±10.2 31547±12.5  32569 ±3.6 
Spreadability (gm.cm/sec)          15.21±2.1 14.56±0.21 14.54±2.87 13.56± 2.45 
% Drug content 98.89±0.25 98.69±0.35 98.98±0.45 98.75±0.35 
Extrudability +++ +++ +++ +++ 
+++ Excellent, ++ Good, + Satisfactory 
Table 6: Characterization of formulations GE5 to G E9 
Parameters 
Formulation  
GF5 GF6 GF7 GF8 GF9 
Physical Appearance 
Translucent, 
white, smooth 
on application 
Translucent, 
white, smooth on 
application 
Translucent, 
white, smooth 
on application 
Translucent, 
white, smooth on 
application 
Translucent, 
white, smooth on 
application 
Ph 6.95±0.3 6.85±0.1 7±0.3 7.03±0.2 7.03±0.2 
Viscosity (CP) 32458±4.5 32569±10.5 33568±10.1          34548±2.5          34987±4.2 
Spreadability (gm.cm/sec)         13.45±2.5 12.15±0.42 11.25±1.35 11.05± 2.5 10.15± 2.45 
% Drug content 99.45±0.32 98.98±0.21 98.98±0.12 98.98±0.4 99.15±0.43 
Extrudability +++ +++ +++ +++ +++ 
In-vitro drug release studies of GE1 to GE9 formulation  
The drug release from the gel is based on concentration of 
rice bran wax used for formulation. The gel formulations 
GE1, GE2, GE3, GE4,  GE5,  GE6, GE7, GE8 and GE9 
containing 0.1%, 0.15%, 0.20%, 0.25%, 0.30%, 0.35%, 
0.45%, 0.50% of carbopol with rice bran wax 0.5%, 0.45%, 
0.40%, 0.35%, 0.30%, 0.25%, 0.20%, 0.15%, 0.10% and 
0.05% showed 82.56%, 85.45%, 93.32%, 96.56%, 99.89%, 
98.79%, 99.10%, 99.87%, and 99.98% drug released at the 
end of 120 min respectively. Drug release was inversely 
proportional to the amount of polymer (Rice bran wax) 
present in the system i.e. the rate and extent of drug release 
increases with decrease in total polymeric content of the 
system. Increasing Rice bran wax concentration decreased 
initial burst release and retards further drug release from 
the gel observed in formulations GE5. Among all 
formulations, GE5 containing 0.30% of Rice bran wax 
showed maximum 99.89% drug release in 120 min, which 
indicated that this concentration of wax can be used as an 
effective rate controlling wax, to retard the release of 
econazole for long period of time i.e. up to 120 min. Same 
concentration of rice bran wax used to formulate gel using 
second model drug 5FU and approximate same results 
found as econazole cream. The selected formulation GE1 
and GF1 was subjected to stability study as per ICH 
guidelines. 
 
 
Figure 1: Zero order release kinetics of all formulation 
 
Figure 2: First order release kinetics of all formulation 
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Figure 3: Higuchi matrix release kinetics data 
 
Figure 4: Peppas release kinetics data
 Drug release kinetics with model fitting of econazole gel 
These values of in-vitro release were attempted to fit into 
various mathematical models, plot of zero order, first order, 
higuchi matrix and peppas. These values were compared 
with each other for model fitting equation. Based on the 
highest regression values (r), the best fit model for all the 
formulations was zero order release kinetics. Further 
Korsmeyer and Peppas equation resulted into the values of 
n > 1, which appears to indicate that the release from the 
prepared optimized gel formulation (GE5) follows Higuchi 
order release Kinetics. 
 
Table 7: Correlation coefficient of Model fitting (r
2
) 
Formulation  code 
Correlation coefficient of Model fitting (R
2
) 
Best fit model 
Zero order First order Higuchi matrix Peppas kinetics 
GE1 0.931 0.942 0.979 0.943 Higuchi 
GE2 0.929 0.989 0.980 0.898 First order 
GE3 0.942 0.969 0.986 0.822 Higuchi 
GE4 0.881 0.973 0.947 0.833 Higuchi 
GE5 0.796 0.888 0.896 0.696 Higuchi 
GE6 0.666 0.909 0.792 0.927 First order 
GE7 0.605 0.880 0.738 0.945 Peppas 
GE8 0.513 0.926 0.649 0.967 Peppas 
GE9 0.497 0.942 0.633 0.943 Peppas 
 
In-vitro drug release studies of GF1 to GF9 formulation  
 
Figure 5: Zero order release kinetics of all formulation 
 
Figure 6: First order release kinetics of all formulation 
 
 
 
Figure 7: Higuchi matrix release kinetics data 
 
Figure 8: Peppas release kinetics data
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Drug release kinetics with model fitting of 5-
Fluorouracil gel 
These values of in-vitro release were attempted to fit into 
various mathematical models, plot of zero order, first order, 
higuchi matrix and peppas. These values were compared 
with each other for model fitting equation. Based on the 
highest regression values (r), the best fit model for all the 
formulations was zero order release kinetics. Further 
Korsmeyer and Peppas equation resulted into the values of 
n > 1, which appears to indicate that the release from the 
prepared optimized gel formulation (GF5) follows higuchi 
order release Kinetics. 
 
 
Table 8: Correlation coefficient of Model fitting (r
2
) 
Formulation  code 
Correlation coefficient of Model fitting (R2) 
Best fit model 
Zero order First order Higuchi matrix Peppas kinetics 
GF1 0.946 0.941 0.986 0.956 Higuchi 
GF2 0.932 0.988 0.982 0.890 First order 
GF3 0.949 0.962 0.984 0.799 Higuchi 
GF4 0.879 0.982 0.949 0.860 First order 
GF5 0.804 0.882 0.902 0.691 Higuchi 
GF6 0.667 0.915 0.792 0.934 Peppas 
GF7 0.603 0.917 0.736 0.921 Peppas 
GF8 0.520 0.917 0.655 0.883 First order 
GF9 0.498 0.921 0.634 0.942 Peppas 
 
Characterization of gel formulation 
Table 9: Results of Characterization of optimized formulation formulations GE5 and GF5 
Parameters 
Formulation 
GE5 GF5 
Physical Appearance Translucent, white, smooth on application Translucent, white, smooth on application 
Ph 6.95±0.3 6.95±0.3 
Viscosity (CP) 32250±7.3 32458±4.5 
Spreadability (gm.cm/sec) 15.59±4.5 13.45±2.5 
% Drug content 99.10±0.4 99.45±0.32 
Extrudability +++ +++ 
 
Drug release kinetics with model fitting of econazole 
and 5 fluorouracil gel  
The data of in-vitro release of formulations was applied on 
different drug release kinetic model to determine release 
kinetic profile. The various mathematical models like zero 
order, first order, higuchi matrix and peppas. These values 
were compared with each other for model fitting equation. 
Based on the highest regression values (r), the best fit 
model for all the gel formulations was zero order release 
kinetics. Higuchi order release Kinetics resulted into the 
values of n > 1, which indicated that the release from the 
prepared optimized gel formulation (GE5) follows Higuchi 
order release Kinetics. 
 
 
Table 10: Correlation coefficient of Model fitting (r
2
) 
Formulation  code 
Correlation coefficient of Model fitting (R
2
) 
Best fit model 
Zero order First order Higuchi matrix Peppas kinetics 
GE5 0.796 0.888 0.896 0.696 Higuchi 
GF5 0.804 0.882 0.902 0.691 Higuchi 
 
Eighteen formulations of gel were prepared nine 
formulations of econazole and nine formulations of 5-
fluorouracil as model drug.  
Gel of econazole and 5-fluorouracil prepared by using rice 
bran wax. Result shows that the physical appearances of the 
gel formulations were Translucent, white and smooth on 
application. The pH of the gel formulations was in the 
range of 6.82±0.1 to 7.03±0.2, which lies in the normal pH 
range of the skin. The pH of optimized formulation of 
econazole loaded gel found to be 6.90±0.8 and pH of 
formulation of 5FU loaded gel was found to be 7.03±0.2, 
which is considered acceptable to avoid the risk of irritation 
upon application to the skin. 
Viscosity of prepared gel was determined by using 
Brookfield Viscometer and were ranging between 
30,250±7.3cp to 32878±2.8 cp & the optimized formulation 
of econazole loaded gel (GE5) was found to be 31454±4.6 
cp and viscosity of optimized formulation of 5FU (GF5)  
loaded gel was found 31454±3.6cp. The values of spread 
ability indicated that the gels were easily spreadable by 
small amount of shear. Spreading of optimized formulation 
of econazole (GE5) and 5-fluorouracil (GF5) gel were 
found to be 16.31±0.58 gm.cm/sec and 20.59±4.5 
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gm.cm/sec respectively, which indicates good spread 
ability of gel. 
Release  of  drug  from  gel  base  was  significantly slower,  
which confirmed  that  slight prolonged drug release rate. 
Incorporation of rice bran wax affected the release rate of 
the drug. By increasing the amount of wax, the release rate 
of the drug decreased, which could be related to the 
increased rigidity of the formulation, followed by its 
decreased permeability for the drug. 
The drug release from the gel is based on concentration of 
rice bran wax used for formulation. The gel formulations 
GE1, GE2, GE3, GE4,  GE5,  GE6, GE7, GE8 and GE9 
containing 0.1%, 0.15%, 0.20%, 0.25%, 0.30%, 0.35%, 
0.45%, 0.50% and 0.55% of carbopol with rice bran wax 
0.55%, 0.50%, 0.45%, 0.40%, 0.35%, 0.30%, 0.25%, 
0.20%, and 0.15% showed 82.56%, 85.45%, 93.32%, 
96.56%, 99.89%, 98.79%, 99.10%, 99.87%, and 99.98% 
drug released at the end of 120 min respectively. Drug 
release was inversely proportional to the amount of 
polymer (Rice bran wax) present in the system i.e. the rate 
and extent of drug release increases with decrease in total 
polymeric content of the system. Increasing Rice bran wax 
concentration decreased initial burst release and retards 
further drug release from the gel observed in formulations 
GE5 and GF5. Among all formulations, GE5 and GF5 
containing 0.35% of Rice bran wax showed maximum 
99.89% and 93.69% drug release respectively in 120 min, 
which indicates that this concentration of wax can be used 
as an effective rate controlling wax, to retard the release of 
econazole for long period of time i.e. up to 120 min.  
These values of in-vitro release were attempted to fit into 
various mathematical models, plot of zero order, first order, 
higuchi matrix and peppas. These values were compared 
with each other for model fitting equation. Based on the 
highest regression values (r), the best fit model for all the 
formulations was zero order release kinetics. Further 
Korsmeyer and Peppas equation resulted into the values of 
n > 1, which appears to indicate that the release from the 
GE5 (r value =0.896) and GF5 (r value = 0.902) follows 
Higuchi order release Kinetics. 
Cytotoxicity assay 
In vitro cytotoxic activity was conducted for 5 FC loaded 
gel against Cell line. Result shows that inhibition of cell 
line by gel containing 5 FC at all concentrations. The IC50 
values for gel were found to be 0.6 ug/ml respectively. 
Anti fungal activity  
In vitro anti fungal activity was conducted for econazole 
loaded gel against Candida Albicans. Result shows that 
Candida albicans was inhibited by the standard antifungal 
agent (econazole), at all the concentration (30 µg/ml). 
Prepared formulations of econazole loaded gel showed 
greater percentage of inhibition against Candida albicans 
indicating higher antifungal activity as compared with 
marketed formulation of econazole due to synergistic effect 
with rice bran wax. 
Skin irritation test 
As all these formulations were prepared for their topical use 
hence tested for skin irritation. The effect of formulations 
on the rat skin was observed after 24, 48, and 72 h. The 
result shows that there were no physical and chemical 
changes and negligible skin irritation scores in case of all 
formulations; Hence, the prepared formulations can be 
considered to be safe for topical application. 
Stability studies  
Stability studies for prepared cream, ointment and gels 
were conducted at 40±2°C/75±5% RH and 30±2°C/60±5% 
RH as per ICH guidelines for a period of 3 months. Results 
of stability studies clearly indicates that optimized batches 
of gel (GE5 & GF5) were stable over the chosen 
temperature and humidity up to 3 months as were no 
significant variation in drug release from these formulation.  
CONCLUSION 
Rice bran wax based formulations (Gel) of 5FU and 
econazole have good appearance, homogeneity, viscosity, 
wash ability, release pattern, less irritant with good 
Anticancer and Antifungal activity respectively. These 
formulations have potential advantages over marketed 
preparations as they improve patient compliance by rapid 
local onset of action for longer period with cost 
effectiveness. Hence present study concludes that rice 
bran wax is excellent base for preparation of semisolid 
formulations including cream, ointment and gel, suitable 
substitute for car carnauba wax as a base for semisolid 
formulations and in some extent it can be used as release 
retardant agent in sustained release dosage form. 
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